Incorrectly-designed mains leads could cause interruption or delay in therapy, regulator warns
Faulty design could cause interruption or delays in the mains supply to vital syringe pump devices, a warning states.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Medical Device Alert concerning all models of Omnifuse syringe pumps - part number 0151-0651 - manufactured by Smiths Medical International.
The warning comes after reports that incorrect design of the mains lead supplied by the company could cause interruption or delay in therapy.
Smiths Medical issued a Field Safety Notice in November, recalling affected products, but has not received enough replies to know that users have received, and acted upon, this information.
The MHRA alert warns anyone still using the devices to quarantine all affected leads and use alternative technology until replacements are obtained.
For more information, email firstname.lastname@example.org or contact 01582 430 330.